Valens GroWorks (formerly Genovation Capital) acquired 100% of Valens Agritech in November 2016 (via reverse takeover) and 100% of Supra THC Services effective March 2017.

Valens Agritech is a biotechnology company based in the Okanagan Valley of British Columbia focused on the cannabis cultivation and research business, with assets and improvements that include a state-of-the-art 17,000 sq ft research and development facility situated on 2 acres in Kelowna. It was awarded its Health Canada-issued Dealers Licence in May 2017 pursuant to the Controlled Drugs and Substances Act and its Regulations and is beginning operations thereunder.

Supra is separately licensed by Health Canada to conduct research, provide chemical analysis and produce extracts and derivatives of cannabis materials, in addition to offering analytical services to the wider natural health product sector. The corporate mandate is to provide scientific leadership and support the production of the highest quality herbal medicinal products on the market.

The Company is also pursuing expedited approved-producer status for medical marijuana under Canada’s ACMPR regulations, in conjunction with a 38,000 sq ft expansion at the Kelowna facility, in anticipation of supplying the adult recreational market once legalized in July 2018.

Website: www.valensgroworks.ca.